The elegant complexity of mammalian ecto-5′-nucleotidase (CD73)

Purinergic signaling is a fundamental mechanism used by all cells to control their internal activities and interact with the environment. A key component of the purinergic system, the enzyme ecto-5 '-nucleotidase (CD73) catalyzes the last step in the extracellular metabolism of ATP to form adenosine. Efforts to harness the therapeutic potential of endogenous adenosine in cancer have culminated in the ongoing clinical development of multiple CD73-targeting antibodies and small-molecule inhibitors. However, recent studies are painting an increasingly complex picture of CD73 mRNA and protein regulation and function in cellular homeostasis, physiological adaptation, and disease development. This review discusses the latest conceptual and methodological advances that are helping to unravel the complexity of this important enzyme that was identified nearly 90 years ago.

Automated summary

Purinergic signaling is a fundamental mechanism used by all cells to control their internal activities and interact with the environment. CD73, a key component of the purinergic system, has been studied in cancer therapy, but recent research shows its complex role in cellular homeostasis, physiological adaptation, and disease development.